|
【参考文献】
1 Freund KB, Yannuzzi LA, Sorenson JA. Agerelated macular degeneration and choroidal neovascularization. Am J Ophthalmol 1993;115:786791
2 Quackenbush EJ, Letarte M. Identification of several cell surface proteins of nonT nonB acute lymphoblastic leukemia by using monoclonal antibodies. J Immuol 1985;134:12761285
3 Akagi K, Ikeda Y, Sumiyoshi Y, et al. Estimation of angiogenesis with antiCD105 immunostaining in the process of colorectal cancer development. Surgery 2002;131:S109113
4 Brewer CA, Setterdahl JJ, Li MJ, et al. Endoglin expression as a measure of microvessel density in cervical cancer. Obstet Gynecol 2000;96:224228
5 Barbara NP, Wrana JL, Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factorβ superfamily. J Biol Chem 1999;274:584594
6 Fonsatti E, Del Vecchio L, Altomonte M, et al. Endoglin: An accessory component of the TGFbetabinding receptorcomplex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies.
J Cell Physiol 2001;188:17
7 Cheifetz S, Bellon T, Cales C, et al. Endoglin is a component of the transforming growth factorβ receptor system in human endothelial cells.
J Biol Chem 1992;267:1902719030
8 Wahl SM. Transforming growth factor beta: the good, the bad, and the ugly. J Exp Med 1994;180:15871590
9 Lastres P, Letamendía A, Zhang H, et al. Endoglin modulates cellular responses to TGFbeta 1. J Cell Biol 1996;133:110911021
10 Li DY, Sorensen LK, Brooke BS, et al. Defective angiogenesis in mice lacking endoglin. Science 1999;284:15341537
11 Li C, Hampson IN, Hampson L,et al. CD105 antagonizes the inhibitory signaling of transforming growth factor beta l on human vascular endothelial cells. FASEB J 2000;14:5564
12 Li C, Guo B, Wilson PB, et al. Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer. Int J Cancer 2000;89:122126
13 Yamashita H, Ichijo H, Grimsby S, et al. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factorbeta. J Bio Chem 1994;269:19952001
14 Tanaka F, Otake Y, Yanagihara K, et al. Evaluation of angiogenesis in nonsmall cell lung cancer: comparison between antiCD34 antibody and antiCD105 antibody. Clin Cancer Res 2001;7:34103415
15 Miller DW, Graulich W, Karges B, et al. Elevated expression of endoglin, a component of the TGFbetareceptor complex, correlates with proliferation of tumor endothelial cells. Int J Cancer 1999;81:568572
16 Fonsatti E, Jekunen AP, Kairemo KJ, et al. Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model. Clin Cancer Res 2000;6:20372043
17官孝群,宋后燕,王文吉,等.血管生成抑制因子k4k5对实验性脉络膜新生血管的抑制作用.中华眼底病杂志 2003;19:217221
18 Grisanti S, Canbek S, Kaiserling E, et al. Expression of endoglin in choroidal neovascularization. Exp Eye Res 2004;78:207213
19孙熠,燕振国,曹虹.病理性新生血管与年龄相关性黄斑病变.国际眼科杂志 2007;7(4):11011103
20 Wikstrom P, Lissbrant IF, Stattin P, et al. CD105 is expressed on immature blood vessels and is a marker for survival in prostate cancer. Prostate 2002;51:268275
21 Cui JZ, Kimura H, Spee C, et al. Natural history of choroidal neovascularization induced by vascular endothelial growth factor in the primate. Graefes Arch Clin Exp Ophthalmol 2000;238:326333
22 Bourdeau A, Faughnan ME, Letarte M. Endoglindeficient mice, a unique model to study hereditary hemorrhagic telangiectasis. Trends Cardiovasc Med 2000;10:279285
23王康,王康孙,王玲,等.激光诱导小鼠脉络膜新生血管模型中CD105的表达.眼科研究 2005;22:2123
24 Tatar O, Shinoda K, Adam A, et al. Expression of endostatin in human choroidal neovascular membranes secondary to agerelated macular degeneration. Exp Eye Res 2006;83:329338
25 Grisanti S, Tatar O, Canbek S, et al. Immunohistopathologic evaluation of choroidal neovascular membranes following verteporfinphotodynamic therapy. Am J Ophthalmol 2004;137:914923
26徐建锋,王雨生,杨秀梅,等.倍频激光诱导的大鼠脉络膜新生血管中CD105的表达.眼科研究 2007;3:2528
27 Fonsatti E, Altomonte M, Nicotra MR, et al. Endoglin(CD105): a powerful therapeutic target on tumorassociated angiogenetic blood vessels. Oncogene 2003;22:65576563
28 Yasukawa T, Kimura H, Tabata Y, et al. Active drug targeting with immunoconjugates to choroidal neovascularization. Curr Eye Res 2000;21:952961
上一页 [1] [2] |
